Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, hair typically does grow back after Mounjaro-related shedding. The loss most people notice is almost never caused by tirzepatide directly damaging hair follicles; it is a physiological response to rapid weight change, and once your body stabilises, regrowth usually begins within a few months. These are prescription-only medicines — a prescriber assesses your suitability before treatment starts.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the most common misconception our prescribers come across. People notice handfuls of hair in the shower and assume tirzepatide is somehow toxic to the scalp. It isn't. The mechanism at play is telogen effluvium, a well-documented, temporary shift in the hair cycle that can be triggered by any significant physical stressor: crash dieting, surgery, illness, pregnancy, or rapid weight loss by any means. Mounjaro itself doesn't appear in the research as a direct cause of follicle damage.
What happens is this: when the body loses weight quickly, it interprets the change as physiological stress. A higher-than-normal proportion of hair follicles shift prematurely into the resting (telogen) phase, and roughly two to four months later that hair sheds. Because the lag is so long, people often connect the shedding to their current dose rather than to the rapid early weight loss months earlier. Tirzepatide's mechanism (slowing gastric emptying, reducing appetite through dual GIP and GLP-1 receptor activation) produces meaningful weight loss precisely because it is effective, and that effectiveness is the indirect trigger.
The NHS notes telogen effluvium as a recognised side effect associated with weight-loss medicines, and the Mounjaro Patient Information Leaflet lists hair loss among possible effects. Recognising what is actually happening matters because the response to each cause is different. Follicle damage would warrant dermatology input; telogen effluvium usually warrants patience and good nutrition.
For the vast majority of people, yes. Telogen effluvium is self-limiting. Once the stressor (in this case, the period of rapid weight change) eases, follicles drift back into the growth (anagen) phase on their own timetable. Regrowth is rarely instant; the hair cycle runs on roughly three-month rhythms, so most people start to notice new growth within three to six months of the shedding settling down.
The clearest sign the cycle is turning is the appearance of short, fine strands along the hairline, often the first visible proof that follicles are waking up again. Full density can take longer. Eighteen months to two years for complete recovery is not unusual after significant telogen effluvium; that feels like a long time, but the trajectory is almost always forwards.
There is a useful parallel in the broader question of what happens after Mounjaro treatment: the body continues to adapt well beyond the last injection. Hair is one part of that adjustment. Weight stabilisation (reaching a plateau rather than continuing rapid loss) is consistently associated with shedding slowing down, even while treatment is ongoing.
If shedding is severe, patchy rather than diffuse, or accompanied by other symptoms, a GP or dermatologist should rule out other causes such as thyroid changes, iron deficiency, or alopecia areata, none of which are caused by Mounjaro but might be unmasked during the period of change.
One factor within your control is nutrition. Telogen effluvium worsens when calorie restriction is severe enough to create nutritional deficits, particularly in protein, iron, zinc and biotin. Tirzepatide reduces appetite substantially; that is the point. But eating too little, or eating in a way that skews heavily towards ultra-processed food low in micronutrients, can deepen the hair-loss phase and prolong recovery.
A practical question our prescribers hear fairly often: how much protein is enough on treatment? There's no single answer that applies to everyone, but general guidance for adults undergoing active weight loss typically points towards at least 1.2–1.6 g of protein per kilogram of target body weight per day. A registered dietitian or your prescriber can help you land on a figure that fits your specific situation. Our Mounjaro information page covers the wider treatment picture, including the lifestyle support that runs alongside medication.
Scalp care, gentle washing routines and avoiding tight hairstyles are commonly cited by dermatologists as sensible during active shedding, not because they reverse the effluvium, but because they reduce mechanical breakage on top of it. Minoxidil (available over the counter in the UK) has reasonable evidence for supporting regrowth in some people; discussion with a GP or dermatologist is worthwhile if shedding feels significant.
For context on what treatment costs look like overall, our Mounjaro price comparison page sets out what a full private prescription typically includes, clinical review, aftercare and follow-up, not just the pen itself.
Hair shedding that fits the telogen effluvium pattern (diffuse, peaking a few months after starting, then gradually easing) does not usually require a change of treatment. But it is always worth raising with whoever is overseeing your care, both for reassurance and to rule out the nutritional gaps mentioned above.
Tell your prescriber promptly if: shedding is sudden and severe rather than gradual; loss is patchy or follows a distinct pattern on the scalp; you're also experiencing fatigue, cold intolerance or other systemic symptoms; or shedding has not improved after six months of weight stability. These presentations go beyond straightforward telogen effluvium and need investigation.
At nume, a real clinician reads your consultation the same day, not software running a checklist. Concerns about hair loss, nutrition and tolerability are exactly the kind of thing that gets discussed during clinical review and in our aftercare. You can also read more about Mounjaro and hair changes in our dedicated overview, or look at the timeline of hair regrowth after Mounjaro for a closer look at what to expect month by month. Our clinical team page gives you a sense of who is doing that reviewing.
If you'd like to explore whether Mounjaro is clinically suitable for you, start your free consultation, no waiting list, same-day clinical review, and free next-working-day delivery once approved.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.